415 Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)Jean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investorsAmed VenturesThe Capital PartnershipNovo HoldingsUnorthodox Ventures
Laza Medical develops an AI- and robotics-powered ultrasound imaging system for structural heart, electrophysiology, and diagnostic cardiac procedures, combining real-time 3D heart modeling, procedural guidance, and robotic probe control.
AI & Machine LearningBiotechMedical DevicesRoboticsCampbell, US
Amr Salahieh(Executive Officer, Director, Promoter)Pablo Garcia Kilroy(General Manager)inCasey Gordon(Director)Mariam Maghribi(Executive Officer)David Voris(Executive Officer)
Co-investorsPage One VenturesThe Capital PartnershipUnorthodox Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.